Mango Sciences Launches to Expand Global Access to Precision Medicine
Summary
Formerly known as Enlightiks Inc. and owned by Practo Technologies, Inc., Mango Sciences continues to develop Querent™ - an advanced predictive artificial intelligence analytics platform that makes deep clinical data meaningful and accessible. “Our unique AI analytics platform not only analyzes large amounts of structured and unstructured health data, but also turns it into functional information with real world applications,” said Vamsi Chandra Kasivajjala, Mango Sciences co-founder and Chief Technology Officer. Prior to co-founding Mango Sciences, Mr. Kasivajjala was the founder of Enlightiks and previously the head of the healthcare division at SRIT building 15 products including EMR, RIs, and PACs before the company was sold to Religare Technologies, Inc. “Ultimately, we are addressing global health inequity and transforming clinical research for millions of people that have been largely overlooked,” said Dr. Mohit Misra, Mango Sciences co-founder and Chief Executive Officer. As we begin a new decade, our approach will drive major advances in patient care not just for emerging markets but for all world populations.” Dr. Misra is a clinician and industry veteran with more than 20 years of experience in global healthcare and life sciences. Mango Sciences is currently partnering with hospitals to understand the health data of individuals in India and other emerging markets to drive advancement in patient care and drug discovery for all populations.